Our People

Ludwig Cancer Research is a community of the world's leading scientists, all pursuing innovative ways to prevent and control cancer. The Ludwig Institute for Cancer Research has an expansive research presence through its branches and collaborative laboratories around the world. In addition, the Ludwig Centers are scientific partners operating independently at six elite U.S. institutions. Learn more.

Baltimore

The Ludwig Center at Johns Hopkins University is focused on identifying the genetic alterations responsible for human tumorigenesis and exploiting this knowledge to manage patients with cancer.

Boston

The Boston area is home to two Ludwig Centers, one at the Harvard Medical School and the other at the Massachusetts Institute of Technology.

Cell biology, Tumor biology
Therapeutics, Signaling
Brussels

The Brussels Branch specializes in cancer immunology and cancer genetics. The laboratories are located within the de Duve Institute on the biomedical campus of the University of Louvain.

Chicago

The Ludwig Center at the University of Chicago is searching for innovative ways to identify, characterize and target disseminated tumor cells.

Lausanne

The Lausanne Branch specializes in cancer immunobiology and immunotherapy research.

Melbourne

Ludwig supports scientists at two locations in Melbourne: the Walter and Eliza Hall Institute of Medical Research and the Olivia Newton-John Cancer Research Institute.

Immunology, Therapeutics
Matthias Ernst, Ludwig Cancer Research, Melbourne
Signaling, Tumor biology
Tumor biology, Clinical trials
Joan Heath, Ludwig Cancer Research
Tumor biology
John Mariadason, Ludwig Institute for Cancer Research, Melbourne
Oncogenic transcription
Andrew Scott, Ludwig Institute for Cancer Research, Melbourne
Signaling, Therapeutics
Genomics, Tumor biology
New York

The Ludwig Institute's technology development program is based in New York, hosting the clinical trials and intellectual property teams. In addition, Memorial Sloan Kettering Cancer Center hosts a Ludwig Center and a Ludwig-supported Collaborative Laboratory.

Pär Olsson, Ludwig Institute for Cancer Research
Intellectual property
Ralph Venhaus, Ludwig Institute for Cancer Research
Clinical trials
Immunology, Clinical trials
Oxford

Scientists at the Oxford Branch are investigating the processes within cells that influence the formation and growth of cancers. The laboratories are housed in the Nuffield Department of Medicine at the University of Oxford.

Gareth L. Bond, Ludwig Institute for Cancer Research, Oxford, UK
Genomics, Tumor biology
Stem cells, Tumor biology
Signaling, Immunology
Skirmantas Kriaucionis, Ludwig Institute for Cancer Research, Oxford, UK
Genomics, Molecular biology
Xin Lu, Ludwig Institute for Cancer Research, Oxford, UK
Tumor biology
Sebastian Nijman, Ludwig Cancer Research Oxford
Cell biology, Signaling, Therapeutics
Peter Ratcliffe, Ludwig Institute for Cancer Research, Oxford, UK
Signaling, Tumor biology
Palo Alto

The Ludwig Center at Stanford University is dedicated to investigating cancer and its treatment from the perspective of stem-cell biology and medicine.

San Diego

The San Diego Branch focuses mainly on cancer genetics, cell signaling, gene regulation and the mechanisms of cell division. The branch is located at the University of California San Diego.

Don W. Cleveland, Ludwig Institute for Cancer Research, San Diego
Cell division, Neuroscience
Signaling, Tumor biology
Richard D. Kolodner, Ludwig Institute for Cancer Research, San Diego
Cell division, Tumor biology
Paul S. Mischel, Ludwig Institute for Cancer Research, San Diego
Signaling, Tumor biology
Karen Oegema, Ludwig Institute for Cancer Research, San Diego
Cell division, Genomics
Bing Ren, Ludwig Institute for Cancer Research, San Diego
Genomics, Stem cells
Andrew Shiau, Ludwig Institute for Cancer Research, San Diego
Small-molecule discovery
Stockholm

The Stockholm Branch, based at the Karolinska Institute, focuses on signaling by growth factors, stem cells and cellular differentiation.

Johan Holmberg, Ludwig Institute for Cancer Research, Stockholm
Stem cells, Tumor biology
Jonas Muhr, Ludwig Institute for Cancer Research, Stockholm
Stem cells, Neuroscience
Thomas Perlmann, Ludwig Institute for Cancer Research, Stockholm
Neuroscience, Stem cells
Tumor biology, Neuroscience
Signaling, Neuroscience
Uppsala

Scientists at the Uppsala Branch are studying the signaling pathways that control cell growth. The branch is based at Uppsala University's Biomedical Center.